First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Status
- RECRUITING
- Phase
- PHASE1
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
- Status
- RECRUITING
- Phase
- N/A
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry
- Status
- RECRUITING
- Phase
- PHASE1
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Long-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
- Status
- RECRUITING
- Phase
- EARLY_PHASE1